<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31364764</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-9861</ISSN><JournalIssue CitedMedium="Internet"><Volume>528</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of comparative neurology</Title><ISOAbbreviation>J Comp Neurol</ISOAbbreviation></Journal><ArticleTitle>Compensatory changes in degenerating spinal motoneurons sustain functional sparing in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>231</StartPage><EndPage>243</EndPage><MedlinePgn>231-243</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cne.24751</ELocationID><Abstract><AbstractText>Plastic changes have been reported in the SOD1-G93A mouse model of amyotrophic lateral sclerosis, a disorder characterized by progressive motoneuronal loss; however, whether these changes related with the onset and development of motor impairments is still unclear. Here, the functional and anatomical changes taking place in SOD1-G93A mice and their time course were investigated during ongoing motoneuronal degeneration. Starting from about 4 postnatal weeks, SOD1-G93A and wild-type (WT) mice were evaluated in the rotarod test, to be sacrificed at about 12-13 or 19&#x2009;weeks of age, and their lumbar spinal cords were processed for histo- and immunohistochemistry. Compared to age-matched WT controls, 12&#x2009;weeks-old SOD1-G93A mice exhibited relatively mild or no motor impairments in the rotarod test, in spite of a dramatic (&#x2248;60%, as estimated by stereology) loss of choline acetyl-transferase (ChAT)-immunoreactive motoneurons which remained virtually unchanged in SOD1-G93A mice surviving up to 19&#x2009;weeks. Notably, the functional sparing in SOD1-G93A mice at 12&#x2009;weeks was paralleled by a marked &#x2248;50% increase in motoneuron volume and a near-normal density of acetylcholinesterase-positive process arborization, which was significantly increased when analyzed as ratio to the decreased number of ChAT-positive motoneurons. By contrast, at 19&#x2009;weeks, when motor deficits had become dramatically evident, both measures were found reverted to about 50-60% of control values. Thus, at specific stages during the progression of the disease, robust compensatory events take place in surviving motoneurons of SOD1-G93A mice, which sustain motor performance, and whose full understanding may highlight a valuable therapeutic opportunity window.</AbstractText><CopyrightInformation>&#xa9; 2019 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Giusto</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>B.R.A.I.N. Laboratory for Neurogenesis and Repair, Department of Life Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Codrich</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>B.R.A.I.N. Laboratory for Neurogenesis and Repair, Department of Life Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Leo</LastName><ForeName>Gioacchino</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>B.R.A.I.N. Laboratory for Neurogenesis and Repair, Department of Life Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francardo</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>B.R.A.I.N. Laboratory for Neurogenesis and Repair, Department of Life Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coradazzi</LastName><ForeName>Marino</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>B.R.A.I.N. Laboratory for Neurogenesis and Repair, Department of Life Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parenti</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, Physiology Section, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Preclinical and Translational Imaging Research Centre - IMPRonTE, University of Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gulisano</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Molecular Preclinical and Translational Imaging Research Centre - IMPRonTE, University of Catania, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Drug Sciences, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vicario</LastName><ForeName>Nunzio</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5934-3962</Identifier><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, Physiology Section, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gulino</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, Physiology Section, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Preclinical and Translational Imaging Research Centre - IMPRonTE, University of Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leanza</LastName><ForeName>Giampiero</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-8609-2561</Identifier><AffiliationInfo><Affiliation>B.R.A.I.N. Laboratory for Neurogenesis and Repair, Department of Life Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Preclinical and Translational Imaging Research Centre - IMPRonTE, University of Catania, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Drug Sciences, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Comp Neurol</MedlineTA><NlmUniqueID>0406041</NlmUniqueID><ISSNLinking>0021-9967</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AB_2783843</Keyword><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">RRID: AB_2313606</Keyword><Keyword MajorTopicYN="N">SOD1-G93A mouse</Keyword><Keyword MajorTopicYN="N">compensatory mechanism</Keyword><Keyword MajorTopicYN="N">functional sparing</Keyword><Keyword MajorTopicYN="N">motoneurons</Keyword><Keyword MajorTopicYN="N">rotarod</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31364764</ArticleId><ArticleId IdType="doi">10.1002/cne.24751</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Ajroud-Driss, S., &amp; Siddique, T. (2015). Sporadic and hereditary amyotrophic lateral sclerosis (ALS). Biochimica et Biophysica Acta, 1852(4), 679-684. https://doi.org/10.1016/j.bbadis.2014.08.010</Citation></Reference><Reference><Citation>Amendola, J., &amp; Durand, J. (2008). Morphological differences between wild-type and transgenic superoxide dismutase 1 lumbar motoneurons in postnatal mice. The Journal of Comparative Neurology, 511(3), 329-341. https://doi.org/10.1002/cne.21818</Citation></Reference><Reference><Citation>Antonini, V., Marrazzo, A., Kleiner, G., Coradazzi, M., Ronsisvalle, S., Prezzavento, O., &#x2026; Leanza, G. (2011). Anti-amnesic and neuroprotective actions of the sigma-1 receptor agonist (-)-MR22 in rats with selective cholinergic lesion and amyloid infusion. Journal of Alzheimer's Disease, 24(3), 569-586. https://doi.org/10.3233/JAD-2011-101794</Citation></Reference><Reference><Citation>Avossa, D., Grandolfo, M., Mazzarol, F., Zatta, M., &amp; Ballerini, L. (2006). Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice. Neuroscience, 138(4), 1179-1194. https://doi.org/10.1016/j.neuroscience.2005.12.009</Citation></Reference><Reference><Citation>Aztiria, E., Cataudella, T., Spampinato, S., &amp; Leanza, G. (2009). Septal grafts restore cognitive abilities and amyloid precursor protein metabolism. Neurobiology of Aging, 30(10), 1614-1625. https://doi.org/10.1016/j.neurobiolaging.2007.12.018</Citation></Reference><Reference><Citation>Bories, C., Amendola, J., Lamotte d'Incamps, B., &amp; Durand, J. (2007). Early electrophysiological abnormalities in lumbar motoneurons in a transgenic mouse model of amyotrophic lateral sclerosis. The European Journal of Neuroscience, 25(2), 451-459. https://doi.org/10.1111/j.1460-9568.2007.05306.x</Citation></Reference><Reference><Citation>Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., &#x2026; Cleveland, D. W. (1997). ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron, 18(2), 327-338.</Citation></Reference><Reference><Citation>Bruijn, L. I., Miller, T. M., &amp; Cleveland, D. W. (2004). Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annual Review of Neuroscience, 27, 723-749. https://doi.org/10.1146/annurev.neuro.27.070203.144244</Citation></Reference><Reference><Citation>Byrne, S., Walsh, C., Lynch, C., Bede, P., Elamin, M., Kenna, K., &#x2026; Hardiman, O. (2011). Rate of familial amyotrophic lateral sclerosis: A systematic review and meta-analysis. Journal of Neurology, Neurosurgery, and Psychiatry, 82(6), 623-627. https://doi.org/10.1136/jnnp.2010.224501</Citation></Reference><Reference><Citation>Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillee, S., Rule, M., &#x2026; Cleveland, D. W. (2003). Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science, 302(5642), 113-117. https://doi.org/10.1126/science.1086071</Citation></Reference><Reference><Citation>Cohen, J. (1988). Statistical power analysis for the behavioural sciences (2nd ed.). Hillsdale, NJ: Erlbaum.</Citation></Reference><Reference><Citation>Coradazzi, M., Gulino, R., Garozzo, S., &amp; Leanza, G. (2010). Selective lesion of the developing central noradrenergic system: Short- and long-term effects and reinnervation by noradrenergic-rich tissue grafts. Journal of Neurochemistry, 114(3), 761-771. https://doi.org/10.1111/j.1471-4159.2010.06800.x</Citation></Reference><Reference><Citation>Dal Canto, M. C., &amp; Gurney, M. E. (1997). A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta Neuropathologica, 93(6), 537-550.</Citation></Reference><Reference><Citation>Dukkipati, S. S., Garrett, T. L., &amp; Elbasiouny, S. M. (2018). The vulnerability of spinal motoneurons and soma size plasticity in a mouse model of amyotrophic lateral sclerosis. The Journal of Physiology, 596(9), 1723-1745. https://doi.org/10.1113/JP275498</Citation></Reference><Reference><Citation>Durand, J., Amendola, J., Bories, C., &amp; Lamotte d'Incamps, B. (2006). Early abnormalities in transgenic mouse models of amyotrophic lateral sclerosis. Journal of Physiology, Paris, 99(2-3), 211-220. https://doi.org/10.1016/j.jphysparis.2005.12.014</Citation></Reference><Reference><Citation>Filipchuk, A. A., &amp; Durand, J. (2012). Postnatal dendritic development in lumbar motoneurons in mutant superoxide dismutase 1 mouse model of amyotrophic lateral sclerosis. Neuroscience, 209, 144-154. https://doi.org/10.1016/j.neuroscience.2012.01.046</Citation></Reference><Reference><Citation>Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A., Wang, M., Castellano-Sanchez, A., &#x2026; Glass, J. D. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Experimental Neurology, 185(2), 232-240.</Citation></Reference><Reference><Citation>Fogarty, M. J., Noakes, P. G., &amp; Bellingham, M. C. (2015). Motor cortex layer V pyramidal neurons exhibit dendritic regression, spine loss, and increased synaptic excitation in the presymptomatic hSOD1(G93A) mouse model of amyotrophic lateral sclerosis. The Journal of Neuroscience, 35(2), 643-647. https://doi.org/10.1523/JNEUROSCI.3483-14.2015</Citation></Reference><Reference><Citation>Gulino, R., Cataudella, T., Casamenti, F., Pepeu, G., Stanzani, S., &amp; Leanza, G. (2007). Acetylcholine release from fetal tissue homotopically grafted to the motoneuron-depleted lumbar spinal cord. An in vivo microdialysis study in the awake rat. Experimental Neurology, 204(1), 326-338. https://doi.org/10.1016/j.expneurol.2006.11.011</Citation></Reference><Reference><Citation>Gulino, R., &amp; Gulisano, M. (2012). Involvement of brain-derived neurotrophic factor and sonic hedgehog in the spinal cord plasticity after neurotoxic partial removal of lumbar motoneurons. Neuroscience Research, 73(3), 238-247. https://doi.org/10.1016/j.neures.2012.04.010</Citation></Reference><Reference><Citation>Gulino, R., Litrico, L., &amp; Leanza, G. (2010). Long-term survival and development of fetal ventral spinal grafts into the motoneuron-depleted rat spinal cord: Role of donor age. Brain Research, 1323, 41-47. https://doi.org/10.1016/j.brainres.2010.02.003</Citation></Reference><Reference><Citation>Gulino, R., Perciavalle, V., &amp; Gulisano, M. (2010). Expression of cell fate determinants and plastic changes after neurotoxic lesion of adult mice spinal cord by cholera toxin-B saporin. The European Journal of Neuroscience, 31(8), 1423-1434. https://doi.org/10.1111/j.1460-9568.2010.07170.x</Citation></Reference><Reference><Citation>Gundersen, H. J., Bagger, P., Bendtsen, T. F., Evans, S. M., Korbo, L., Marcussen, N., et al. (1988). The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS, 96(10), 857-881.</Citation></Reference><Reference><Citation>Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., et al. (1994). Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 264(5166), 1772-1775.</Citation></Reference><Reference><Citation>Hamson, D. K., Hu, J. H., Krieger, C., &amp; Watson, N. V. (2002). Lumbar motoneuron fate in a mouse model of amyotrophic lateral sclerosis. Neuroreport, 13(17), 2291-2294. https://doi.org/10.1097/01.wnr.0000047541.58765.24</Citation></Reference><Reference><Citation>Hedreen, J. C., Bacon, S. J., &amp; Price, D. L. (1985). A modified histochemical technique to visualize acetylcholinesterase-containing axons. The Journal of Histochemistry and Cytochemistry, 33(2), 134-140. https://doi.org/10.1177/33.2.2578498</Citation></Reference><Reference><Citation>Hegedus, J., Putman, C. T., Tyreman, N., &amp; Gordon, T. (2008). Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. The Journal of Physiology, 586(14), 3337-3351. https://doi.org/10.1113/jphysiol.2007.149286</Citation></Reference><Reference><Citation>Karnovsky, M. J., &amp; Roots, L. (1964). A "direct-Coloring" Thiocholine method for Cholinesterases. The Journal of Histochemistry and Cytochemistry, 12, 219-221. https://doi.org/10.1177/12.3.219</Citation></Reference><Reference><Citation>Kiernan, J. A., &amp; Hudson, A. J. (1991). Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis. Brain, 114(Pt 2), 843-853.</Citation></Reference><Reference><Citation>Leroy, F., Lamotte d'Incamps, B., Imhoff-Manuel, R. D., &amp; Zytnicki, D. (2014). Early intrinsic hyperexcitability does not contribute to motoneuron degeneration in amyotrophic lateral sclerosis. ELife, 3. https://doi.org/10.7554/eLife.04046</Citation></Reference><Reference><Citation>Mancuso, R., Olivan, S., Osta, R., &amp; Navarro, X. (2011). Evolution of gait abnormalities in SOD1(G93A) transgenic mice. Brain Research, 1406, 65-73. https://doi.org/10.1016/j.brainres.2011.06.033</Citation></Reference><Reference><Citation>McGoldrick, P., Joyce, P. I., Fisher, E. M., &amp; Greensmith, L. (2013). Rodent models of amyotrophic lateral sclerosis. Biochimica et Biophysica Acta, 1832(9), 1421-1436. https://doi.org/10.1016/j.bbadis.2013.03.012</Citation></Reference><Reference><Citation>Miana-Mena, F. J., Munoz, M. J., Yague, G., Mendez, M., Moreno, M., Ciriza, J., &#x2026; Osta, R. (2005). Optimal methods to characterize the G93A mouse model of ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 6(1), 55-62. https://doi.org/10.1080/14660820510026162</Citation></Reference><Reference><Citation>Moens, T. G., Partridge, L., &amp; Isaacs, A. M. (2017). Genetic models of C9orf72: What is toxic? Current Opinion in Genetics &amp; Development, 44, 92-101. https://doi.org/10.1016/j.gde.2017.01.006</Citation></Reference><Reference><Citation>Monville, C., Torres, E. M., &amp; Dunnett, S. B. (2006). Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model. Journal of Neuroscience Methods, 158(2), 219-223. https://doi.org/10.1016/j.jneumeth.2006.06.001</Citation></Reference><Reference><Citation>Nijssen, J., Comley, L. H., &amp; Hedlund, E. (2017). Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathologica, 133(6), 863-885. https://doi.org/10.1007/s00401-017-1708-8</Citation></Reference><Reference><Citation>Petrov, D., Mansfield, C., Moussy, A., &amp; Hermine, O. (2017). ALS clinical trials review: 20&#x2009;years of failure. Are we any closer to registering a new treatment? Front Aging Neurosci, 9(68). https://doi.org/10.3389/fnagi.2017.00068</Citation></Reference><Reference><Citation>Ramirez Jarquin, U. N., &amp; Tapia, R. (2016). Neuropathological characterization of spinal motor neuron degeneration processes induced by acute and chronic excitotoxic stimulus in vivo. Neuroscience, 331, 78-90. https://doi.org/10.1016/j.neuroscience.2016.06.021</Citation></Reference><Reference><Citation>Rasband, W. S., &amp; Bright, D. S. (1995). Nih image-A public domain image-processing program for the Macintosh. Microbeam Analysis, 4(3), 137-149.</Citation></Reference><Reference><Citation>Riacho, J., Ruiz-Soto, M., Villagr&#xe1;, N. T., Berciano, J., Berciano, M. T., &amp; Lafarga, M. (2014). Compensatory motor neuron response to chromatolysis in the murine hSOD1G93A model of amyotrophic lateral sclerosis. Frontiers in Cellular Neuroscience, 8, 346. https://doi.org/10.3389/fncel.2014.00346</Citation></Reference><Reference><Citation>Ripps, M. E., Huntley, G. W., Hof, P. R., Morrison, J. H., &amp; Gordon, J. W. (1995). Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 92(3), 689-693.</Citation></Reference><Reference><Citation>Rowland, L. P., &amp; Shneider, N. A. (2001). Amyotrophic lateral sclerosis. The New England Journal of Medicine, 344(22), 1688-1700. https://doi.org/10.1056/NEJM200105313442207</Citation></Reference><Reference><Citation>Santa-Cruz, L. D., &amp; Tapia, R. (2014). Role of energy metabolic deficits and oxidative stress in excitotoxic spinal motor neuron degeneration in vivo. ASN Neuro, 6(2). https://doi.org/10.1042/AN20130046</Citation></Reference><Reference><Citation>Satoh, K., Armstrong, D. M., &amp; Fibiger, H. C. (1983). A comparison of the distribution of central cholinergic neurons as demonstrated by acetylcholinesterase pharmacohistochemistry and choline acetyltransferase immunohistochemistry. Brain Research Bulletin, 11(6), 693-720.</Citation></Reference><Reference><Citation>Schaefer, A. M., Sanes, J. R., &amp; Lichtman, J. W. (2005). A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. The Journal of Comparative Neurology, 490(3), 209-219. https://doi.org/10.1002/cne.20620</Citation></Reference><Reference><Citation>Swinnen, B., &amp; Robberecht, W. (2014). The phenotypic variability of amyotrophic lateral sclerosis. Nature Reviews. Neurology, 10(11), 661-670. https://doi.org/10.1038/nrneurol.2014.184</Citation></Reference><Reference><Citation>Talbott, E. O., Malek, A. M., &amp; Lacomis, D. (2016). The epidemiology of amyotrophic lateral sclerosis. Handbook of Clinical Neurology, 138, 225-238. https://doi.org/10.1016/B978-0-12-802973-2.00013-6</Citation></Reference><Reference><Citation>Taylor, J. P., Brown, R. H., Jr., &amp; Cleveland, D. W. (2016). Decoding ALS: From genes to mechanism. Nature, 539(7628), 197-206. https://doi.org/10.1038/nature20413</Citation></Reference><Reference><Citation>Turner, B. J., &amp; Talbot, K. (2008). Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Progress in Neurobiology, 85(1), 94-134. https://doi.org/10.1016/j.pneurobio.2008.01.001</Citation></Reference><Reference><Citation>West, M. J., Slomianka, L., &amp; Gundersen, H. J. (1991). Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. The Anatomical Record, 231(4), 482-497. https://doi.org/10.1002/ar.1092310411</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>